For the twelve months ended Jun 30, 2026, United States Antimony Corporation reported $36.44M of revenue and -$16.25M of net income.
UAMY revenueQ2 2026$7.93M
- Quarter YoY
- -24.7%
- QoQ
- +16.8%
- FY YoY
- +162.8%
- 5Y CAGR
- +49.6%
- 10Y CAGR
- +11.6%
UAMY revenue was $7.93M in fiscal Q2 2026 (ended Jun 30, 2026), down 24.7% from a year earlier and up 16.8% from the prior quarter. For the full fiscal 2025 it was $39.26M, up 162.8% from fiscal 2024. Compound annual growth was +49.6% over 5 years and +11.6% over 10 years. It rose in 4 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.
UAMY net incomeQ2 2026$110.3K
- Quarter YoY
- -39.3%
UAMY net income was $110.3K in fiscal Q2 2026 (ended Jun 30, 2026), down 39.3% from a year earlier. For the full fiscal 2025 it was -$4.34M, compared with -$1.73M in fiscal 2024.
UAMY EPSQ1 2026-$0.08
UAMY diluted EPS was -$0.08 in fiscal Q1 2026 (ended Mar 31, 2026), compared with $0.00 a year earlier. For the full fiscal 2025 it was -$0.04, compared with -$0.02 in fiscal 2024.
UAMY free cash flowQ2 2026-$18.89M
UAMY free cash flow was -$18.89M in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$7.16M a year earlier. For the full fiscal 2025 it was -$37.50M, compared with $1.79M in fiscal 2024.
Source: XBRL data United States Antimony Corporation files with the SEC, latest filing dated Aug 11, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.